Skip to content
Home › 13F recaps › Q3 2026 › TEVA

Which funds bought or sold TEVA in Q3 2026?

Teva Pharmaceutical Inds Ltd. 13 funds bought, 1 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$855M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold TEVA, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (13)

FundChangeEst. $Now
BlackRock
Index giant
New+$2.5B$2.5B
Vanguard Capital
Index giant
Added+1225060.2%+$1.3B$1.3B
Geode
Index giant
New+$470M$470M
Glenview
Hedge fund
New+$300M$300M
Capital World
Asset manager
Added+43.6%+$217M$713M
Arrowstreet
Quant & multi-strategy
Added+902.9%+$188M$209M
Susquehanna
Quant & multi-strategy
New+$117M$117M
Marshall Wace
Quant & multi-strategy
New+$110M$110M
Legal & General
Asset manager
Added+60.8%+$95M$250M
CPP Investments
Sovereign & pension
Added+135.1%+$84M$146M
DME / Greenlight
Value investor
New+$72M$72M
Adage
Hedge fund
Added+74.1%+$69M$163M
GQG
Growth / crossover
New+$19M$19M

Sold (1)

FundChangeEst. $Now
Northern Trust
Bank & broker
Trimmed-25.6%−$81M$234M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.